MoneyWorks4Me

Ajanta Pharma - Quaterly Results

31 Jan 2024 Evaluate
The December 2023 quarter revenue stood at Rs. 10852.90 millions, up 24.05% as compared to Rs. 8748.90 millions during the corresponding quarter last year.Handsome Net Profit growth of 77.60% reported above the corresponding previous quarter figure of Rs. 2201.50 millions to Rs. 1239.60 millions.Operating profit surged to 3409.10 millions from the corresponding previous quarter of 1899.20 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 10852.90 8748.90 24.05 30450.50 25624.10 18.84 34112.70 31406.40 8.62
Other Income 137.30 305.10 -55.00 973.50 1443.00 -32.54 1327.50 1397.30 -5.00
PBIDT 3409.10 1899.20 79.50 9750.80 6507.50 49.84 8320.30 10306.20 -19.27
Interest 23.60 26.80 -11.94 53.80 40.20 33.83 52.30 91.20 -42.65
PBDT 3385.50 1872.40 80.81 9697.00 6467.30 49.94 8268.00 10215.00 -19.06
Depreciation 334.10 322.90 3.47 986.90 948.40 4.06 1269.50 1209.60 4.95
PBT 3051.40 1549.50 96.93 8710.10 5518.90 57.82 6998.50 9005.40 -22.29
TAX 849.90 309.90 174.25 2264.60 1103.80 105.16 1411.30 1806.80 -21.89
Deferred Tax 30.50 134.60 -77.34 87.10 55.20 57.79 -29.30 95.10 -130.81
PAT 2201.50 1239.60 77.60 6445.50 4415.10 45.99 5587.20 7198.60 -22.38
Equity 252.70 257.10 -1.71 252.70 257.10 -1.71 252.70 171.70 47.18
PBIDTM(%) 31.41 21.71 44.70 32.02 25.40 26.09 24.39 32.82 -25.67
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..